Recent

% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

  • dragan7777777777 dragan7777777777 Dec 10, 2010 5:36 AM Flag

    Today....

    Friday, December 10

    Abstract: P2-09-05


    Poster Session 2 (Prognostic and Predictive Factors: Response Predictions - Biomarkers and Other Factors): "Risk group selection in primary breast cancer according to ASCO-recommended biomarkers of Oncotype DX and uPA-PAI-1: First experience from prospective multicenter WSG Plan B trial"
    Lead Author: T. Degenhardt, MD, West German Study Group
    Location: Exhibit Halls A-B
    Time: 7 a.m. – 9 a.m.


    Abstract: P2-09-06

    Poster Session 2 (Prognostic and Predictive Factors: Response Predictions - Biomarkers and Other Factors): "Meta-analysis of the decision impact of the 21-gene breast cancer Recurrence Score® in clinical practice"

    Lead Author: John Hornberger, MD, MS, CEO & President, Cedar Associates LLC and Adjunct Professor of Medicine, Stanford University
    Location: Exhibit Halls A-B
    Time: 7 a.m. – 9 a.m.

    Abstract: S4-9

    General Session 4: "Comparing the prediction of chemotherapy benefit in patients with node-negative, ER-positive breast cancer using the Recurrence Score and a new measure that integrates clinical and pathologic factors with the Recurrence Score"

    Presenter: Gong Tang, PhD, Assistant Professor of Biostatistics, University of Pittsburgh and Statistician, the NSABP Biostatistical Center
    Location: Exhibit Hall D
    Time: 3:15 p.m. – 5:30 p.m.


    Abstract: P3-10-01

    Poster Session 3 (Prognostic and Predictive Factors: Prognostic Factors & Biomarkers-Clinical Testing and Validation): "Quantitative gene expression analysis in a large cohort of estrogen-receptor positive breast cancers: Characterization of the tumor profiles in younger patients (<40 yrs) and in older patients (>70 yrs)"

    Lead Author: Steven Shak, MD, Genomic Health
    Location: Exhibit Halls A-B
    Time: 5:30 p.m. - 7:30 p.m.


    Abstract: P3-10-12

    Poster Session 3 (Prognostic and Predictive Factors: Prognostic Factors & Biomarkers-Clinical Testing and Validation): Pilot Phase of the Randomized Plan B Trial: Prospective Comparison of Molecular Classification, Oncotype DX and Clinical-Pathological Characteristics in Hormone-Receptor (HR) Positive Primary Breast Cancer

    Lead Author: Oleg Gluz, MD, West German Study Group
    Location: Exhibit Halls A-B
    Time: 5:30 p.m. - 7:30 p.m.


    Abstract: P3-10-13

    Poster Session 3 (Prognostic and Predictive Factors: Prognostic Factors & Biomarkers-Clinical Testing and Validation): "Prognostic value of genomic analysis after neoadjuvant chemotherapy for breast cancer"
    Lead Author: Erica L. Mayer, MD MPH, Staff Physician, Breast Oncology Center
    Dana-Farber Cancer Institute and Instructor in Medicine, Harvard Medical School

    Location: Exhibit Halls A-B
    Time: 5:30 p.m. - 7:30 p.m.

    Abstract: P3-10-15

    Poster Session 3 (Prognostic and Predictive Factors: Prognostic Factors & Biomarkers-Clinical Testing and Validation): "Quantitative gene expression by RT-PCR in classic and variant forms of lobular carcinoma in estrogen receptor positive invasive breast cancer"
    Lead Author: Joseph M. Anderson, MD, Genomic Health
    Location: Exhibit Halls A-B
    Time: 5:30 p.m. - 7:30 p.m.

 
GHDX
26.28Apr 29 4:00 PMEDT